The poster, titled Translational Insights from a First-in-Human Study of an Oral CBL-B Inhibitor in Advanced Solid Tumors, expands upon data presented at the recent European Society for Medical ...

Presented new preclinical data on INB-619, a novel gamma-delta (γδ) T cell engager (TCE), demonstrating equivalent potency ...

Human progenitors are programmed into ependymal cells in brain organoids via GEMC1 and MCIDAS expression. This strategy ...

Pivotal Phase 2 ALPHA3 Trial with Cemacabtagene Ansegedleucel (Cema-Cel) in First Line (1L) Consolidation in Large B-Cell Lymphoma (LBCL) ALPHA3 ...

Dispatch Bio, a biotech company engineering a universal treatment across solid tumors leveraging its first-in-class Flare platform, today announced a clinical supply and collaboration agreement with ...

Science learns from nature's methods - Potential benefits for future therapies against cancer and Alzheimer's disease - Joint research by TUM and Helmholtz Munich In the fight against disease, ...

A collection of studies that chart how mammalian brain cells grow and differentiate is a ‘very valuable’ tool for ...

Urolithin A, a natural postbiotic known to trigger mitophagy, rejuvenated key immune cell functions in healthy middle-aged ...

To make the therapy safer and more adaptable, UChicago researchers developed a new “split” system called GA1CAR. This uses ...

Autism Spectrum Disorder is a complex condition with rising global prevalence. Research indicates it stems from a blend of ...

Data to be presented at the 40th Annual Society for Immunotherapy of Cancer (SITC) Meeting on November 7th and 9th ...